David Wallon

20.8k total citations
68 papers, 1.2k citations indexed

About

David Wallon is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, David Wallon has authored 68 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 27 papers in Neurology and 19 papers in Molecular Biology. Recurrent topics in David Wallon's work include Alzheimer's disease research and treatments (27 papers), Dementia and Cognitive Impairment Research (14 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). David Wallon is often cited by papers focused on Alzheimer's disease research and treatments (27 papers), Dementia and Cognitive Impairment Research (14 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). David Wallon collaborates with scholars based in France, United Kingdom and United States. David Wallon's co-authors include Didier Hannequin, Dominique Campion, Thierry Frébourg, Anne Rovelet‐Lecrux, David Maltête, Gaël Nicolas, Stéphane Derrey, Cyril Pottier, Olivier Martinaud and Romain Lefaucheur and has published in prestigious journals such as Neurology, Stroke and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

David Wallon

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Wallon France 21 454 410 288 264 191 68 1.2k
Masamitsu Takatama Japan 18 722 1.6× 402 1.0× 364 1.3× 256 1.0× 103 0.5× 75 1.3k
Friederike Knerlich‐Lukoschus Germany 18 152 0.3× 278 0.7× 299 1.0× 210 0.8× 62 0.3× 37 1.4k
Meng‐Cheong Wong Singapore 18 420 0.9× 89 0.2× 183 0.6× 222 0.8× 145 0.8× 30 1.0k
Ki‐Wook Oh South Korea 22 855 1.9× 197 0.5× 395 1.4× 229 0.9× 49 0.3× 58 1.4k
Stacey Melquist United States 17 163 0.4× 280 0.7× 438 1.5× 107 0.4× 100 0.5× 31 1.3k
Zhenzhen Zheng China 20 669 1.5× 187 0.5× 274 1.0× 135 0.5× 36 0.2× 72 1.2k
Rosa Guerrero Spain 17 163 0.4× 284 0.7× 232 0.8× 50 0.2× 121 0.6× 38 802
Christa L. Hladik United States 19 485 1.1× 418 1.0× 626 2.2× 158 0.6× 63 0.3× 28 1.5k
Lucie Guyant‐Maréchal France 15 421 0.9× 289 0.7× 398 1.4× 233 0.9× 209 1.1× 31 1.0k
E. Peter Bosch United States 19 464 1.0× 197 0.5× 222 0.8× 88 0.3× 78 0.4× 35 1.2k

Countries citing papers authored by David Wallon

Since Specialization
Citations

This map shows the geographic impact of David Wallon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wallon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wallon more than expected).

Fields of papers citing papers by David Wallon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wallon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wallon. The network helps show where David Wallon may publish in the future.

Co-authorship network of co-authors of David Wallon

This figure shows the co-authorship network connecting the top 25 collaborators of David Wallon. A scholar is included among the top collaborators of David Wallon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wallon. David Wallon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wallon, David & Antoine Garnier‐Crussard. (2025). The challenging concept of preclinical Alzheimer's disease. Revue Neurologique. 181(9). 881–892.
2.
Grangeon, Lou, Camille Charbonnier, Stéphane Rousseau, et al.. (2024). Input of exome sequencing in early‐onset cerebral amyloid angiopathy. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 16(4). e70027–e70027. 1 indexed citations
3.
4.
Camporesi, Elena, Eleni Gkanatsiou, Susana Boluda, et al.. (2024). Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome. Acta Neuropathologica. 148(1). 8–8. 5 indexed citations
5.
Grangeon, Lou, David Wallon, Bertrand Bourre, et al.. (2024). Development of an Objective Structured Clinical Examination (OSCE) to evaluate the diagnosis announcement of chronic neurological disease by residents in neurology. Revue Neurologique. 180(7). 655–660. 1 indexed citations
6.
Maltête, David, et al.. (2023). Impact of previous statin use on first intracerebral hemorrhage in cerebral amyloid angiopathy. Revue Neurologique. 179(10). 1074–1080. 1 indexed citations
7.
Provost, C., Anne Rovelet‐Lecrux, C. Monzo, et al.. (2023). Generation of induced pluripotent stem cell lines IRMBi003-A and IRMBi003-B from a healthy donor to model Alzheimer’s disease. Stem Cell Research. 73. 103250–103250.
8.
Maltête, David, David Wallon, Romain Lefaucheur, et al.. (2020). Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia. Neurology. 96(5). e684–e697. 24 indexed citations
9.
Bertoux, Maxime, Thibaud Lebouvier, Florence Lebert, et al.. (2020). Does amnesia specifically predict Alzheimer’s pathology? A neuropathological study. Neurobiology of Aging. 95. 123–130. 14 indexed citations
10.
Monzo, C., David Wallon, Anne Rovelet‐Lecrux, et al.. (2019). Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene. Stem Cell Research. 37. 101438–101438. 3 indexed citations
11.
Monzo, C., David Wallon, Anne Rovelet‐Lecrux, et al.. (2019). Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene. Stem Cell Research. 34. 101381–101381. 8 indexed citations
12.
Barbier, Mathieu, David Wallon, & Isabelle Le Ber. (2018). Monogenic inheritance in early-onset dementia: illustration in Alzheimer's disease and frontotemporal lobar dementia. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. 16(3). 289–297. 2 indexed citations
13.
Bousiges, Olivier, Stéphanie Bombois, Susanna Schraen‐Maschke, et al.. (2018). Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer’s disease at the prodromal stage. Journal of Neurology Neurosurgery & Psychiatry. 89(5). 467–475. 30 indexed citations
14.
Chen, Yaohua, Jean Dallongeville, David Wallon, et al.. (2017). Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer’s Disease. Journal of Alzheimer s Disease. 60(3). 1045–1054. 21 indexed citations
15.
Guennec, Kilan Le, Sarah Veugelen, Olivier Quenez, et al.. (2017). Deletion of exons 9 and 10 of the Presenilin 1 gene in a patient with Early-onset Alzheimer Disease generates longer amyloid seeds. Neurobiology of Disease. 104. 97–103. 16 indexed citations
16.
Mouton‐Liger, François, David Wallon, Anne‐Cécile Troussière, et al.. (2013). Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study. Journal of Neurology. 261(1). 144–151. 43 indexed citations
17.
Ber, Isabelle Le, Gaël Nicolas, Agnès Camuzat, et al.. (2013). hnRNPA2B1 and hnRNPA1 mutations are rare in patients with “multisystem proteinopathy” and frontotemporal lobar degeneration phenotypes. Neurobiology of Aging. 35(4). 934.e5–934.e6. 51 indexed citations
18.
Bugnicourt, Jean‐Marc, E. Guégan-Massardier, Martine Roussel, et al.. (2012). Cognitive impairment after cerebral venous thrombosis: a two-center study. Journal of Neurology. 260(5). 1324–1331. 35 indexed citations
19.
Lefaucheur, Romain, et al.. (2012). Recurrent diplopia over a 30-year period: natural history of a Lewis and Sumner syndrome. Acta Neurologica Belgica. 112(2). 199–201. 1 indexed citations
20.
Hannequin, Didier, Lucie Guyant‐Maréchal, Isabelle Le Ber, et al.. (2009). Démences du sujet jeune : démarche diagnostique. Revue Neurologique. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masamitsu Takatama Breakdown of academic impact, for papers by Friederike Knerlich‐Lukoschus Breakdown of academic impact, for papers by Meng‐Cheong Wong Breakdown of academic impact, for papers by Ki‐Wook Oh Breakdown of academic impact, for papers by Stacey Melquist Breakdown of academic impact, for papers by Zhenzhen Zheng Breakdown of academic impact, for papers by Rosa Guerrero Breakdown of academic impact, for papers by Christa L. Hladik Breakdown of academic impact, for papers by Lucie Guyant‐Maréchal Breakdown of academic impact, for papers by E. Peter Bosch
Rankless by CCL
2026